基于β-Cyclodextrin的几何丧的两动物作为单组分,细胞特异和器官特异的核酸输送系统
Gonzalo Rivero-Barbarroja1, José López-Fernández2, Inmaculada Juárez-Gonzálvez3
1Department of Organic Chemistry, Faculty of Chemistry, University of Seville, 41012 Sevilla, Spain.
Carbohydrate polymers
|November 1, 2024
概括
我们开发了基于循环德克斯的新型几何丧两体 (GFA),用于核酸输送. 这些GFA展示了可调节的自我组装和选择性器官向,显示了作为先进分子载体的前景.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 分子医学是分子医学.
背景情况:
- 开发高效和选择性的核酸输送载体对于基因疗法至关重要.
- 现有的基于环氧的系统往往缺乏对自组装和准的精确控制.
- 需要新的分子架构来克服当前的交付限制.
研究的目的:
- 介绍和表征一种新的类型的基于循环德克斯特林的几何丧两动物 (GFA) 核酸输送.
- 调查GFA的自我组装特性和DNA复杂化行为.
- 评估GFA-核酸纳米复合物的体外和体内传染效率和器官向选择性.
主要方法:
- 基于β-cyclodextrin的几何挫折两动物 (GFA) 的合成和表征.
- 研究GFA在pH值上依赖的自我组装成囊泡和分子形式.
- 形成和表征GFA-等离子体DNA (pDNA) 纳米复合体,包括拓和内部顺序分析.
- 在体外细胞转染研究以评估输送效率.
- 在体内研究以确定器官向结果.
主要成果:
- GFA 呈现出独特的功能组分布,使其能够访问单分散变体.
- 根据pH值,GFA的自我组装成不同的结构 (双层囊泡,单层囊泡,单个分子).
- GFA-pDNA纳米复合体显示可调节的拓和内部顺序,首选的形安排.
- 根据GFA架构,观察到体外传染性能和体内器官向 (肝脏,肺,脏,) 的显著差异.
结论:
- 基于循环德的GFAs代表了核酸输送的有前途的新型分子载体.
- GFA的分子架构允许对自我组装和DNA复杂化进行微调.
- GFA 显示了实现选择性细胞和器官转染的潜力,为有针对性的基因传递应用铺平了道路.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165


